OKA Yoshihiro | Department of Molecular Medicine, Osaka University Graduate School of Medicine

スポンサーリンク

概要

関連著者

もっと見る

著作論文

Monitoring Minimal Residual Disease in Leukemia Using Real-time Quantitative Polymerase Chain Reaction for Wilms Tumor Gene (WT1)
Expression of the Wilms' Tumor Gene WT1 in Solid Tumors and Its Involvement in Tumor Cell Growth
Unmanipulated Reduced-Intensity Stem Cell Transplantation from a Haploidentical Donor Mismatched at 3 HLA Antigens to a Patient with Leukemic Transformation of Myelodysplastic Syndrome : Successful Second Transplantation after Graft Rejection
Sensitive immunohistochemical detection of WT1 protein in tumors with anti-WT1 antibody against WT1 235 peptide
High frequencies of less differentiated and more proliferative WT1-specific CD8^+ T Cells in bone marrow in tumor-bearing patients : An important role of bone marrow as a secondary lymphoid organ
Biased usage of BV gene families of T-cell receptors of WT1 (Wilms' tumor gene)-specific CD8^+ T cells in patients with myeloid malignancies
Overexpression of the Wilms' tumor gene WT1 in pancreatic ductal adenocarcinoma
Overexpression of the Wilms' tumor gene WT1 in primary astrocytic tumors
Wilms Tumor Gene WT1 Peptide-Based Immunotherapy Induced a Minimal Response in a Patient with Advanced Therapy-Resistant Multiple Myeloma
WT1_, a Ninemer Peptide Derived from Wilms' Tumor Gene Product, Is a Candidate Peptide for the Vaccination of HLA-A^*0201-Positive Patients with Hematopoietic Malignancies
Successful Treatment of Tacrolimus (FK506)-Related Leukoencephalopathy with Cerebral Hemorrhage in a Patient Who Underwent Nonmyeloablative Stem Cell Transplantation
WT1 Peptide-Based Immunotherapy for Patients with Lung Cancer : Report of Two Cases
Wilms Tumor Gene Peptide-Based Immunotherapy for Patients with Overt Leulemia from Myelodysplastic Syndrome (MDS) or MDS with Myelofibrosis
The lck Promoter-Driven Expression of the Wilms Tumor Gene WT1 Blocks Intrathymic Differentiation of T-Lineage Cells
Wilms' tumor gene WT1 17AA(-)/KTS(-) isoform induces morphological changes and promotes cell migration and invasion in vitro
WT1 (Wilms' Tumor 1) Peptide Immunotherapy for Renal Cell Carcinoma
Overexpression of the Wilms′tumor gene WT1 in head and neck squamous cell carcinoma
Efficient Induction of Pptide - Specific Cytotoxic T Lymphocytes by LPS - Activated Spleen Cells
Identification of a WT1 protein-derived peptide, WT1_, : as a HLA-A^*0206-restricted, WT1-specific CTL epitope
A WT1 protein-derived, naturally processed 16-mer peptide, WT1_, is a promiscuous helper peptide for induction of WT1-specific Th1-type CD4^+ T cells
Successful treatment of acquired hemophilia A, complicated by chronic GVHD, with tocilizumab

もっと見る

スポンサーリンク